⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

HAE

Haemonetics Corporation

Healthcare · Medical Devices

103.16USD

+0.3200 (+0.31%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End03/2026
Last Quarter End06/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 103.16
P/E48.7
Dvd Ind Yld—
P/B5.61
P/S3.5
Curr EV/T12M EBITDA20.9
Mkt Cap (USD)4.7B
Curr EV (USD)5.6B
2)

Per Share Data

EPS T12M2.05
DPS—
Bk Val Per Sh18.41
Rev/Sh29.58
Cash/Sh4.94
Curr Shares Out45.5M
FCF/Sh6.37
3)

Cash Flow Analysis

P/CF14.3
Curr P/FCF16.1
CF/NI3.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales24.3%
Eff Interest Rate1.6%
4)

Growth Potential

Dil EPS 1Y Gr-38.1%
Cap 1Y Gr-1.2%
BPS 1Y Gr3.9%
R&D To Sales4.4%
Retention Rate100.0%
Rev 1Y Gr-2.0%
FCF 1Y Gr82.8%
Assets 1Y Gr-2.2%
5)

Profitability

EBITDA0.3B
EBIT0.2B
Operating Margin11.9%
Pretax Margin9.6%
Net Margin7.1%
ROA4.0%
ROE11.2%
ROC5.9%
Asset Turnover0.56
6)

Structure

Current Ratio3.08
Quick Ratio1.67
Debt/Assets49.6%
Debt/Com Eq140.3%
Net Debt/EBITDA3.52
Tot Debt/Capital58.4%
Gross Margin59.0%
EBIT/Int Exp8.3

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.